Hang Yu
Impact in
- Drug Discovery top 5%
- Biological Psychiatry top 10%
Papers in
-
- Traditional Chinese Medicine Analysis 8
- Medicinal Plant Extracts Effects 3
-
- Berberine and alkaloids research 6
- Pharmacogenetics and Drug Metabolism 4
- Co-authors
- Li‐Bin Pan (16 shared papers)Shurong Ma (10 shared papers)Jian‐Dong Jiang (10 shared papers)Ran Peng (8 shared papers)Pei Han (4 shared papers)Jie Fu (6 shared papers)Zhengwei Zhang (5 shared papers)Lin Cong (3 shared papers)
In The Last Decade
Hang Yu
46 papers receiving 1.4k citations
Hang Yu's Hit Papers
Peers
Comparison fields: 5 of 101
- Drug Discovery 11
- Biological Psychiatry 24
- Complementary and alternative medicine 149
- Nephrology 135
- Pharmacology 150
Countries citing papers authored by Hang Yu
This map shows the geographic impact of Hang Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hang Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hang Yu more than expected).
Fields of papers citing papers by Hang Yu
This network shows the impact of papers produced by Hang Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hang Yu. The network helps show where Hang Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Hang Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Oral berberine improves brain dopa/dopamine levels to ameliorate Parkinson’s disease by regulating gut microbiota Hit paper breakdown → | 2021 | 275 |
| 2 | 2019 | 166 | |
| 3 | 2022 | 147 | |
| 4 | 2022 | 115 | |
| 5 | 2021 | 93 | |
| 6 | 2022 | 64 | |
| 7 | 2017 | 58 | |
| 8 | 2020 | 43 | |
| 9 | 2022 | 34 | |
| 10 | 2022 | 30 | |
| 11 | 2021 | 25 | |
| 12 | 2023 | 25 | |
| 13 | 2023 | 24 | |
| 14 | 2022 | 23 | |
| 15 | 2022 | 23 | |
| 16 | 2021 | 22 | |
| 17 | 2023 | 22 | |
| 18 | 2022 | 21 | |
| 19 | 2023 | 21 | |
| 20 | 2023 | 17 |
About Hang Yu
Hang Yu is a scholar working on Complementary and alternative medicine, Pharmacology, Pharmacology, Molecular Biology and Biological Psychiatry, having authored 49 papers that have together received 1.4k indexed citations. Recurring topics across this work include Gut microbiota and health (18 papers), Traditional Chinese Medicine Analysis (8 papers), Berberine and alkaloids research (6 papers), Pharmacogenetics and Drug Metabolism (4 papers), Carbon and Quantum Dots Applications (3 papers), Asthma and respiratory diseases (3 papers), Medicinal Plant Extracts Effects (3 papers) and Phytochemicals and Antioxidant Activities (2 papers). The work is most often cited by research in Drug Discovery (11 citations), Biological Psychiatry (24 citations), Complementary and alternative medicine (149 citations), Nephrology (135 citations) and Pharmacology (150 citations). Hang Yu has collaborated with scholars based in China, Hong Kong and Germany. Frequent co-authors include Li‐Bin Pan, Shurong Ma, Jian‐Dong Jiang, Ran Peng, Pei Han, Jie Fu, Zhengwei Zhang, Lin Cong, Zhengwei Zhang and Qian Tong. Their work appears in journals such as Molecules, Journal of Asian Natural Products Research, Acta Pharmaceutica Sinica B, Engineering and Signal Transduction and Targeted Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.